Cystic Fibrosis APIs Three-Drug Therapy
Business
- 2 month, 21 days ago
Sigachi Industries advances cystic fibrosis APIs with Vanzacaftor, Tezacaftor and Deutivacaftor, targeting a long-term growth opportunity in niche therapies.